These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 7925842

  • 1. Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
    Richard MG, Bennett JP.
    Exp Neurol; 1994 Sep; 129(1):57-63. PubMed ID: 7925842
    [Abstract] [Full Text] [Related]

  • 2. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D, Abercrombie ED, Zigmond MJ.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
    [Abstract] [Full Text] [Related]

  • 3. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 4. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D, Salah RS, Galloway MP.
    Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

  • 6. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST, Baella SA, Stuebner NM, Crawford CA, McDougall SA.
    Brain Res; 2006 Feb 16; 1073-1074():269-75. PubMed ID: 16427034
    [Abstract] [Full Text] [Related]

  • 7. Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice.
    Kirchhoff J, Mørk A, Brennum LT, Sager TN.
    Neuroreport; 2009 Mar 25; 20(5):482-6. PubMed ID: 19262413
    [Abstract] [Full Text] [Related]

  • 8. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
    Date I, Asari S, Nishimoto A, Felten DL.
    No To Shinkei; 1990 Nov 25; 42(11):1035-40. PubMed ID: 2076347
    [Abstract] [Full Text] [Related]

  • 9. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 25; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 10. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA, Wüllner U, Heneka MT, Schulz JB, Kunow M, Wachtel H, Klockgether T.
    Synapse; 1997 Aug 25; 26(4):381-91. PubMed ID: 9215597
    [Abstract] [Full Text] [Related]

  • 11. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K, Kondo T, Narabayashi H.
    No To Shinkei; 1987 Jul 25; 39(7):663-72. PubMed ID: 3314916
    [Abstract] [Full Text] [Related]

  • 12. L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation.
    Borah A, Mohanakumar KP.
    Neurochem Int; 2010 Jan 25; 56(2):357-62. PubMed ID: 19931335
    [Abstract] [Full Text] [Related]

  • 13. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
    Snyder GL, Keller RW, Zigmond MJ.
    J Pharmacol Exp Ther; 1990 May 25; 253(2):867-76. PubMed ID: 2110978
    [Abstract] [Full Text] [Related]

  • 14. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P, Abercrombie ED.
    J Pharmacol Exp Ther; 1996 May 25; 277(2):775-83. PubMed ID: 8627558
    [Abstract] [Full Text] [Related]

  • 15. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F, Alessandrì MG, Torracca MT, Bassi L, Corsini GU.
    J Pharmacol Exp Ther; 1997 Oct 25; 283(1):100-7. PubMed ID: 9336313
    [Abstract] [Full Text] [Related]

  • 16. Preservation of autoreceptor-mediated increases in dopamine synthesis in aged mice with experimentally-induced parkinsonism.
    Schneider JS.
    Neurosci Lett; 1997 Jan 31; 222(2):138-40. PubMed ID: 9111748
    [Abstract] [Full Text] [Related]

  • 17. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I, Kehr J, Andbjer B, Fuxe K.
    Exp Neurol; 2000 Jul 31; 164(1):154-65. PubMed ID: 10877926
    [Abstract] [Full Text] [Related]

  • 18. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T.
    Mol Pharmacol; 1996 Nov 31; 50(5):1073-9. PubMed ID: 8913337
    [Abstract] [Full Text] [Related]

  • 19. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS, Tham CS, Wilson C, Jakubovic A, Fibiger HC.
    J Pharmacol Exp Ther; 1993 Mar 31; 264(3):1344-51. PubMed ID: 8095550
    [Abstract] [Full Text] [Related]

  • 20. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK, Keyghobadi M, Moore C, Meshul CK.
    Neuroscience; 2005 Mar 31; 136(1):333-41. PubMed ID: 16198485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.